Nitrosamine Impurities Affecting Drug-Drug Interaction Studies – Learn More

About

News & Events

News

Celerion Receives a 2023 CRO Leadership Award in All Categories for the Eighth Year Running

05.10.23

Celerion Expands Its Service Offering to Include GLP/GCP Compliant Molecular and Cell Biology Testing

11.10.22

CRO Leadership Award Goes to Celerion for a 7th Consecutive Year

06.15.22

All News

Events

Continuing the Conversation: Audience Questions from ASCPT Journal Family Webinar “Alternatives for Rifampin as a CYP3A Inducer in DDI Studies in View of N-Nitrosamine Impurity Issues”

12.01.2023 - 12.01.2023

All Events

Blog Posts

Adaptive Trial Designs

06.29.22

A Decade of Innovative Technology to Accelerate Drug Development

08.04.20

The Platforms and Promise of COVID-19 Vaccines

07.07.20

All Blog Posts